Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
11 |
Material Type: Artigo
|
![]() |
72PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)Moreno, V ; Gil-Martin, M ; Johnson, M L ; Aljumaily, R ; Lopez Criado, P ; Northfelt, D W ; Crittenden, M ; Jabbour, S ; Rosen, L ; Garrido, P ; Hervás Morón, A ; Rietschel, P ; Mohan, K K ; Li, J ; Stankevich, E ; Feng, M ; Lowy, I ; Fury, M GAnnals of oncology, 2018-12, Vol.29 (suppl_10) [Periódico revisado por pares]Oxford University PressTexto completo disponível |
12 |
Material Type: Artigo
|
![]() |
1162PCemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)Moreno, V ; Gil-Martin, M ; Johnson, M ; Aljumaily, R ; Lopez Criado, P ; Northfelt, D W ; Crittenden, M ; Jabbour, S ; Rosen, L ; Garrido Lopez, P ; Hervás Morón, A ; Rietschel, P ; Mohan, K K ; Li, J ; Stankevich, E ; Rowlands, T ; Feng, M ; Lowy, I ; Fury, M GAnnals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]Oxford University PressTexto completo disponível |